These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 1319804

  • 1. [Determination of plasma level of platelet activating factor in cirrhotic patients and its relation to endotoxemia].
    Zeng N.
    Zhonghua Yi Xue Za Zhi; 1992 Mar; 72(3):141-3, 189. PubMed ID: 1319804
    [Abstract] [Full Text] [Related]

  • 2. Platelet-activating factor antagonist TCV-309 attenuates the induction of the cytokine network in experimental endotoxemia in chimpanzees.
    Kuipers B, van der Poll T, Levi M, van Deventer SJ, ten Cate H, Imai Y, Hack CE, ten Cate JW.
    J Immunol; 1994 Mar 01; 152(5):2438-46. PubMed ID: 8133055
    [Abstract] [Full Text] [Related]

  • 3. [Determination of platelet activating factor and platelet associated IgG in pregnancy-induced hypertension].
    Zhang S, Zhang Y, Liu B.
    Zhonghua Fu Chan Ke Za Zhi; 1996 May 01; 31(5):296-8. PubMed ID: 9206185
    [Abstract] [Full Text] [Related]

  • 4. High plasma levels of von Willebrand factor as a marker of endothelial perturbation in cirrhosis: relationship to endotoxemia.
    Ferro D, Quintarelli C, Lattuada A, Leo R, Alessandroni M, Mannucci PM, Violi F.
    Hepatology; 1996 Jun 01; 23(6):1377-83. PubMed ID: 8675154
    [Abstract] [Full Text] [Related]

  • 5. Plasma prekallikrein and endotoxemia in liver cirrhosis.
    van Vliet AC, van Vliet HH, Dzoljić-Danilović G, Wilson JH.
    Thromb Haemost; 1981 Feb 23; 45(1):65-7. PubMed ID: 7018004
    [Abstract] [Full Text] [Related]

  • 6. Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia.
    Guarner C, Soriano G, Tomas A, Bulbena O, Novella MT, Balanzo J, Vilardell F, Mourelle M, Moncada S.
    Hepatology; 1993 Nov 23; 18(5):1139-43. PubMed ID: 8225220
    [Abstract] [Full Text] [Related]

  • 7. Endotoxemia, encephalopathy, and mortality in cirrhotic patients.
    Bigatello LM, Broitman SA, Fattori L, Di Paoli M, Pontello M, Bevilacqua G, Nespoli A.
    Am J Gastroenterol; 1987 Jan 23; 82(1):11-5. PubMed ID: 3799574
    [Abstract] [Full Text] [Related]

  • 8. Prognostic value of plasma endotoxin levels in patients with cirrhosis.
    Chan CC, Hwang SJ, Lee FY, Wang SS, Chang FY, Li CP, Chu CJ, Lu RH, Lee SD.
    Scand J Gastroenterol; 1997 Sep 23; 32(9):942-6. PubMed ID: 9299675
    [Abstract] [Full Text] [Related]

  • 9. [Pathogenetic effect of platelet activating factor on enterogenic endotoxemia after burn].
    Yu P, Xiao G, Fu W.
    Zhonghua Yi Xue Za Zhi; 1999 Feb 23; 79(2):136-8. PubMed ID: 11601022
    [Abstract] [Full Text] [Related]

  • 10. Sequential changes in plasma cytokine and endotoxin levels in cirrhotic patients with bacterial infection.
    Wang SS, Lee FY, Chan CC, Lu RH, Chao Y, Lin HC, Wu SL, Tsai YT, Lee SD.
    Clin Sci (Lond); 2000 Apr 23; 98(4):419-25. PubMed ID: 10731475
    [Abstract] [Full Text] [Related]

  • 11. Plasma endothelin levels in cirrhotic patients and their correlation with atrial natriuretic peptide.
    Chen YX, Wang SC, Zhao GN, Tang J, Zhang SX, Tang CS.
    Chin Med J (Engl); 1993 Sep 23; 106(9):643-6. PubMed ID: 8287696
    [Abstract] [Full Text] [Related]

  • 12. Plasma platelet activating factor in nephrotic syndrome.
    Camici M, Sagripanti A.
    Minerva Med; 2001 Oct 23; 92(5):325-7. PubMed ID: 11675576
    [Abstract] [Full Text] [Related]

  • 13. [Clinical investigation of vitamin A deficiency and endotoxemia in patients with liver cirrhosis].
    Zeng NX, Wang JL, Guo JY.
    Zhonghua Nei Ke Za Zhi; 1992 Feb 23; 31(2):77-9, 125. PubMed ID: 1395918
    [Abstract] [Full Text] [Related]

  • 14. Endotoxemia of cirrhosis: an observation not substantiated.
    Fulenwider JT, Sibley C, Stein SF, Evatt B, Nordlinger BM, Ivey GL.
    Gastroenterology; 1980 May 23; 78(5 Pt 1):1001-4. PubMed ID: 6991352
    [Abstract] [Full Text] [Related]

  • 15. Plasma substance P levels in patients with liver cirrhosis: relationship to systemic and portal hemodynamics.
    Lee FY, Lin HC, Tsai YT, Chang FY, Lu RH, Hou MC, Li CP, Chu CJ, Wang SS, Lee SD.
    Am J Gastroenterol; 1997 Nov 23; 92(11):2080-4. PubMed ID: 9362197
    [Abstract] [Full Text] [Related]

  • 16. The role of platelet-activating factor in conscious, normotensive endotoxemia.
    Ephgrave K, Kremer T, Broadhurst K, Cullen J.
    J Surg Res; 1997 Mar 23; 68(2):170-4. PubMed ID: 9184676
    [Abstract] [Full Text] [Related]

  • 17. Platelet-activating factor and anti-platelet-aggregating factor in acute reduction of blood pressure following percutaneous transluminal renal angioplasty in patients with renovascular hypertension.
    Masugi F, Ogihara T, Saeki S, Sakaguchi K, Kumahara Y.
    J Hum Hypertens; 1988 Aug 23; 2(2):111-6. PubMed ID: 2977405
    [Abstract] [Full Text] [Related]

  • 18. [Effect of anti-endotoxin therapy on vaso-active substances in decompensated liver cirrhosis].
    Zhuang L, Ma Z, Liu T.
    Zhonghua Gan Zang Bing Za Zhi; 2000 Apr 23; 8(2):94-5. PubMed ID: 10861114
    [Abstract] [Full Text] [Related]

  • 19. Blood levels of platelet-activating factor in endotoxin-sensitive and endotoxin-resistant mice during endotoxemia.
    Chang TW, Wu MH, Yang YJ.
    J Formos Med Assoc; 1992 Dec 23; 91(12):1133-7. PubMed ID: 1363632
    [Abstract] [Full Text] [Related]

  • 20. Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrhosis.
    Genesca J, Gonzalez A, Segura R, Catalan R, Marti R, Varela E, Cadelina G, Martinez M, Lopez-Talavera JC, Esteban R, Groszmann RJ, Guardia J.
    Am J Gastroenterol; 1999 Jan 23; 94(1):169-77. PubMed ID: 9934750
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.